ClinicalTrials.gg
Active, not recruitingNCT06176469POLSTONEUpdated Feb 11, 2025

Renal Colic and Urolithiasis in Poland

An observational study in Renal Colic and Urolithiasis, sponsored by Mikolaj Przydacz. Active, not recruiting at 1 site in Poland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-02-11.

Sponsored by Mikolaj Przydacz · Observational

Study type
Observational
Model
Ecologic or community
Time perspective
Cross-sectional
Enrollment
10,000
Ages
18 Years and older
Sex
All
01

Study summary

The aim of this study is to analyze the prevalence, effect on quality of life, and treatment-related behaviors for renal colic and urolithiasis in a population-representative sample of Poles. We will be using an Internet interview format for renal colic and urolithiasis evaluation. The study will include respondents representative for age and place of residence with adequate proportions of respondents from urban and rural areas.

02

Conditions studied

  • Renal Colic
  • Urolithiasis
03

In context

Renal Colic

79 studies on the registry are indexed under Renal Colic; 10 are open to participants now.

This study's planned enrollment of 10,000 is above the median of 452 across 16 observational studies indexed under Renal Colic.

Browse Renal Colic studies →

Lead sponsor

This is the only study on the registry with Mikolaj Przydacz as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Probability sample

Study population

A representative pool of men and women in Poland

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • consent to participate

Exclusion criteria

Exclusion Criteria:

  • lack of consent to participate
05

Study design

Observational model
Ecologic or community
Time perspective
Cross-sectional
Enrollment
10,000 participants (estimated)
Patient registry
No

Groups and cohorts

  • Population-level and representative cohort

    Other: No intervention

Interventions

  • OtherNo intervention

    No intervention

06

What researchers measure

Primary outcomes

  1. Prevalence of renal colic and urolithiasis in Poland

    Prevalence of renal colic and urolithiasis in Poland

    Time frame: December 2023 - December 2024

07

Study locations

1 site
  • Department of Urology, Jagiellonian University
    Krakow, Poland
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Dec 2023 to primary completion in Jun 2024, 6 months.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 9, 2023
First posted
Dec 19, 2023
StartActual
Dec 1, 2023
Primary completionActual
Jun 1, 2024
CompletionEst.
Jun 30, 2025
Last update
Feb 11, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 11, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06176469
Lead sponsor
Mikolaj Przydacz
Responsible party
Mikolaj Przydacz (Associate Professor, Jagiellonian University) — Sponsor-investigator
First posted
Dec 19, 2023
Start date
Dec 1, 2023
Primary completion
Jun 1, 2024
Completion
Jun 30, 2025 (estimated)
Last update
Feb 11, 2025

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion